Long term streptomycin toxicity in the treatment of Buruli Ulcer: follow-up of participants in the BURULICO drug trial.
Buruli Ulcer (BU) is a tropical infectious skin disease that is currently treated with 8 weeks of intramuscular streptomycin and oral rifampicin. As prolonged streptomycin administration can cause both oto- and nephrotoxicity, we evaluated its long term toxicity by following-up former BU patients th...
Main Authors: | Sandor Klis, Ymkje Stienstra, Richard O Phillips, Kabiru Mohammed Abass, Wilson Tuah, Tjip S van der Werf |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-03-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC3953024?pdf=render |
Similar Items
-
Good quality of life in former Buruli ulcer patients with small lesions: long-term follow-up of the BURULICO trial.
by: Sandor Klis, et al.
Published: (2014-07-01) -
Former Buruli Ulcer Patients' Experiences and Wishes May Serve as a Guide to Further Improve Buruli Ulcer Management.
by: Anita Velink, et al.
Published: (2016-12-01) -
Genetic Susceptibility and Predictors of Paradoxical Reactions in Buruli Ulcer.
by: Yves Thierry Barogui, et al.
Published: (2016-04-01) -
Towards rational use of antibiotics for suspected secondary infections in Buruli ulcer patients.
by: Yves T Barogui, et al.
Published: (2013-01-01) -
Persisting social participation restrictions among former Buruli ulcer patients in Ghana and Benin.
by: Janine de Zeeuw, et al.
Published: (2014-11-01)